Press Release Biocartis Group NV: Biocartis to Host Webcast for Announcement 2019 Financial Results on 5 March 2020

NEXT STORY
Basilea reports the launch of antifungal Cresemba® (isavuconazole) in Australia triggering the first milestone payment related to Asia-Pacific
PREV STORY
Esperion Announces FDA Approval of the NEXLIZET™ (bempedoic acid and ezetimibe) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NuGenerex Immuno-Oncology Announces Shareholder Conference Call on Thursday October 8, 2020 at 8:00 AM

author_avatar
NASDAQ Market News

Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply

author_avatar
NASDAQ Market News

Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs

ALPHARETTA, Ga., July 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical ...

author_avatar
NASDAQ Market News